Pulse Biosciences, Inc. PLSE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -10,392.1%+11,590pp | -21,982.6%+69,816pp | -91,798.8%— | —— | —— | |
| Net margin | -9,929%+10,866pp | -20,794.6%+66,104pp | -86,898.8%— | —— | —— | |
| EBITDA margin | -10,252.7%+11,423pp | -21,675.4%+68,841pp | -90,516.3%— | —— | —— | |
| Free cash flow margin | -7,390%+8,163pp | -15,553.4%+41,161pp | -56,714%— | —— | —— | |
| Returns | ||||||
| Return on equity | -80.7%-6.3pp | -74.4%+12.5pp | -87%+16.5pp | -103.5%-25.6pp | -77.9%-10.6pp | |
| Return on assets | -69.4%-5.2pp | -64.1%+9.9pp | -74.1%+10.6pp | -84.7%-18.7pp | -66%-10.1pp | |
| Return on invested capital | -1,211.5%-43.4pp | -1,168.1%-26.9pp | -1,141.3%-227pp | -914.4%-209pp | -705.7%+51.4pp | |
| Efficiency | ||||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×— | 0×— | 0×— | |
| Inventory turnover | 7.7×— | —— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 7.3×-3.3× | 10.5×+0.5× | 10×-2.0× | 12×-3.5× | 15.6×+3.7× | |
| Quick ratio | 7.2×-3.3× | 10.5×+0.5× | 10×-2.0× | 12×-3.5× | 15.6×+3.7× | |
| Cash ratio | 7×-3.2× | 10.2×+0.4× | 9.8×-2.0× | 11.8×-3.5× | 15.4×+3.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -22.1×-3.8× | -18.4×+0.2× | -18.6×-1.5× | -17.1×+1.3× | -18.4×+2.6× | |
| Valuation | ||||||
| Market capitalization | $1.47B+57.8% | $930.45M-21.9% | $1.19B+15.0% | $1.04B-2.3% | $1.06B-1.0% | |
| Enterprise value | $1.41B+64.1% | $857.24M-22.3% | $1.1B+17.7% | $937.91M-1.3% | $950.05M-1.2% | |
| Price / sales | 1,954.6×-704× | 2,658.4×-11,192× | 13,850.4×— | —— | —— | |
| Price / book | 22.1×+10.6× | 11.5×-1.3× | 12.9×+2.9× | 9.9×+1.0× | 9×-0.4× | |
| EV / sales | 1,873.1×-576× | 2,449.3×-10,386× | 12,835×— | —— | —— | |
| Free cash flow yield | -3.8%+2.1pp | -5.9%-1.8pp | -4.1%+0.2pp | -4.3%-0.5pp | -3.8%-0.4pp | |
| Earnings yield | -5.1%+2.7pp | -7.8%-1.5pp | -6.3%+0.3pp | -6.6%-0.9pp | -5.7%-0.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Pulse Biosciences, Inc. (PLSE) runs a -4067.5% gross margin and a -10392.1% operating margin, with a -9929.0% net margin.
- Where do Pulse Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Pulse Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.